DermaSensor, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
DermaSensor, Inc. - overview
Established
2009
Location
Miami, FL, US
Primary Industry
Medical Devices & Equipment
About
Based in Florida, US, and founded in 2009, DermaSensor operates as a health technology company. The company was founded by Maurice Ferre and Christopher Dewey. In October 2024, DermaSensor, Inc. raised USD 16 million in series B funding from Pier 70 Ventures, Kern Venture Group, GenHenn Capital and other unspecified investors.
As of 2022, the company’s CEO is Cody Simmons. DermaSensor offers a skin cancer care device, which is a skin cancer prevention instrument that helps to evaluate the risk of skin cancer. The device uses non-invasive optical spectroscopy to find early detection of skin cancer. It provides results directly to the user without the assistance of a laboratory or another doctor.
Current Investors
Harmonix, SternAegis Ventures, Miami Angels
Primary Industry
Medical Devices & Equipment
Sub Industries
Healthcare IT, Monitoring Equipment, Diagnostic Equipment
Website
www.dermasensor.com
Verticals
HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only
DermaSensor, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.